The healthcare and life sciences industries face a continually evolving business and regulatory landscape, resulting in a wide range of disputes. Successfully navigating these challenges requires in-depth knowledge of the economic issues in this field combined with a deep understanding of the industry.
The Brattle Group’s experts and consultants combine economic principles, proficiency with institutional features, and extensive data analytics capabilities to assist our clients with issues that arise in disputes, investigations, and regulatory proceedings. We provide economic expertise and expert testimony on matters related to pharmaceuticals, biologics, medical devices, providers, and health insurers.
We are known for developing accessible and persuasive analyses grounded in economic and financial principles, as well as for our close working relationships with leading academics and industry practitioners. We have particular expertise in leveraging data analytics tools to obtain insights from massive healthcare datasets, which can include billions of observations.
Mr. Fanaras has more than two decades of experience analyzing antitrust and competition issues and evaluating economic damages, specializing in matters involving healthcare and technology industries. He has provided economic analyses for matters before courts, in arbitration, and in regulatory proceedings.